A detailed history of New York State Common Retirement Fund transactions in Replimune Group, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,973 shares of REPL stock, worth $129,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,973
Previous 17,547 31.77%
Holding current value
$129,308
Previous $158,000 17.09%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$8.09 - $11.23 $45,093 - $62,596
-5,574 Reduced 31.77%
11,973 $131,000
Q2 2024

Jul 31, 2024

BUY
$5.01 - $9.46 $34,944 - $65,983
6,975 Added 65.98%
17,547 $158,000
Q1 2024

May 07, 2024

BUY
$6.87 - $9.31 $21,839 - $29,596
3,179 Added 43.0%
10,572 $86,000
Q4 2023

Feb 01, 2024

SELL
$6.75 - $16.18 $61,006 - $146,234
-9,038 Reduced 55.01%
7,393 $62,000
Q3 2023

Nov 07, 2023

BUY
$15.96 - $22.18 $1,197 - $1,663
75 Added 0.46%
16,431 $281,000
Q2 2023

Aug 07, 2023

SELL
$15.65 - $24.1 $78,046 - $120,186
-4,987 Reduced 23.37%
16,356 $380,000
Q1 2023

May 02, 2023

SELL
$17.48 - $29.09 $117,116 - $194,903
-6,700 Reduced 23.89%
21,343 $377,000
Q4 2022

Jan 30, 2023

BUY
$17.09 - $27.91 $50,996 - $83,283
2,984 Added 11.91%
28,043 $763,000
Q3 2022

Nov 08, 2022

BUY
$15.6 - $21.15 $63,195 - $85,678
4,051 Added 19.28%
25,059 $433,000
Q2 2022

Aug 04, 2022

SELL
$13.32 - $19.98 $745 - $1,118
-56 Reduced 0.27%
21,008 $367,000
Q1 2022

May 05, 2022

BUY
$15.24 - $29.75 $304 - $595
20 Added 0.1%
21,064 $358,000
Q4 2021

Feb 02, 2022

BUY
$25.43 - $34.25 $42,722 - $57,540
1,680 Added 8.68%
21,044 $570,000
Q3 2021

Nov 02, 2021

SELL
$28.98 - $39.54 $96,184 - $131,233
-3,319 Reduced 14.63%
19,364 $574,000
Q2 2021

Aug 02, 2021

BUY
$28.5 - $39.37 $5,386 - $7,440
189 Added 0.84%
22,683 $871,000
Q4 2020

Feb 08, 2021

BUY
$23.5 - $52.65 $126,900 - $284,310
5,400 Added 31.59%
22,494 $858,000
Q2 2020

Aug 07, 2020

BUY
$9.76 - $25.95 $38,064 - $101,205
3,900 Added 29.56%
17,094 $425,000
Q4 2019

Feb 05, 2020

SELL
$11.61 - $17.21 $6,966 - $10,326
-600 Reduced 4.35%
13,194 $189,000
Q2 2019

Aug 09, 2019

BUY
$12.51 - $17.28 $91,323 - $126,144
7,300 Added 112.41%
13,794 $202,000
Q4 2018

Feb 08, 2019

BUY
$9.97 - $15.57 $64,745 - $101,111
6,494 New
6,494 $65,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $533M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.